- Home
- ALDX vs USIO Comparison
ALDX vs USIO Comparison
Compare ALDX & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALDX | USIO |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.1M | 83.5M |
| IPO Year | 2014 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ALDX | USIO |
|---|---|---|
| Price | $0.92 | $2.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $6.60 | $5.92 |
| AVG Volume (30 Days) | ★ 950.4K | 258.5K |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.43 | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $28,200,535.00 |
| Revenue This Year | N/A | $14.57 |
| Revenue Next Year | N/A | $11.98 |
| P/E Ratio | ★ N/A | $276.00 |
| Revenue Growth | N/A | ★ 12.69 |
| 52 Week Low | $1.07 | $1.03 |
| 52 Week High | $5.93 | $3.06 |
Technical Indicators
Market Signals| Indicator | ALDX | USIO |
|---|---|---|
| Relative Strength Index (RSI) | 31.33 | 68.41 |
| Support Level | N/A | $2.15 |
| Resistance Level | $1.58 | $3.03 |
| Average True Range (ATR) | 0.11 | 0.16 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 5.00 | 89.61 |
Price Performance
Historical ComparisonAbout ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About USIO Usio Inc.
Usio Inc is a cloud-based Fintech payment processor. The company serves multiple industry verticals with technology that facilitates payment acceptance and funds disbursement in a single, full-stack ecosystem. It provides payment acceptance through multiple payment methods, including payment facilitation, prepaid card, and electronic billing products and services to businesses, merchants, and consumers. The company's reportable operating segments are Output Solutions and Merchant Services, and these segments.